Evaluation of the Effect of an APP in Improving Treatment Adherence in Hypertensive Patients in Hypertension Ambulatory

Blood Pressure Clinical Trial

Official title:

Evaluation of the Effect of an APP in Improving Treatment Adherence in Hypertensive Patients in Hypertension Ambulatory

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04475367
• Other study ID #: 5701-19
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 10, 2020
• Est. completion date: December 30, 2021

Study information

• Verified date: July 2020
• Source: Instituto de Cardiologia do Rio Grande do Sul
• Contact: Ana Paula Reis, Nurse
• Phone: +555132303600
• Email: areis9874[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Brief Summary: Through the App, the user will have the opportunity to connect directly with the health professional, clarify doubts and manage the treatment of their hypertension.

Description:

To evaluate treatment adherence and blood pressure reduction, through the HiperCross App, between two groups of hypertensive patients in a Hypertension Public Ambulatory in Porto Alegre.

The investigators hope to identify better adherence to treatment, as well as a significant reduction in blood pressure, all of these results will be better evaluated using the HiperCross application.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 44
• Est. completion date: December 30, 2021
• Est. primary completion date: December 20, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• hypertensive patients admitted to the hypertension clinic at Instituto de Cardiologia

• older 18 years

Exclusion Criteria:

• Patients without a mobile phone compatible with the App

Related Conditions & MeSH terms

• Adhesion
• Blood Pressure
• Hypertension

Intervention

Other:
• App hypercross group
hypertensive patients using HyperCrossApp
• without App hypercross group
Interdisciplinary health care

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Instituto de Cardiologia do Rio Grande do Sul

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Blood pressure value	systolic Blood pressure and dyastolic Blood pressure	15 minutes
Secondary	Morisky scale	Medication adherence. The Morisky scale condition and medication specific assessment: 1) measures the level of adherence an medication, 2) measures the severity of Major Depressive Disorder, a determinant of non-adherence 3) identifies why the patient is not taking their medication, 4) determines the risk between non-adherence to BP measures of disease control. 0-1 = Low motivation; 2-3 = High motivation / 0-1 = Low knowledge; 2-3 = High knowledge	15 minutes